chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hot body; my arm was also in little pain; fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING HOT (non-serious), outcome "unknown", described as "hot body"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "my arm was also in little pain"; PYREXIA (non-serious), outcome "unknown", described as "fever".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Follow-up (11Feb2022): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Initial report received on 12 December 2007 from a health care professional in the United States. A 19 year-old male patient received on 30 October 2007 Menactra (lot#U2427AA) and at the evening of the same day, began having pain in his entire left arm. He had pain when he moved his arm a certain way and he could not lift a weight over his head. The muscle felt tired. There was no redness or swelling. Treated with Medrol dose pack with no change (in his condition). The patient was seen again by a physician as the pain was becoming worse. Naproxen was prescribed but there was no change (in his condition). The patient was planning to see an orthopedic PhD and to get an MRI. No relevant laboratory or diagnostic tests were done. The patient had no illness at vaccination time. No other vaccines were given around the same time. The patient's medical history included: NKA (No Known Allergies), asthma, anxiety and depression. The patient's concomitant medications included: albuterol inhaler, Clonipine and Zoloft. No adverse event was reported following prior vaccination. The patient had not recovered. Upon internal review: the initial report received on 11 December 2007 (and not as reported previously) from a health care professional.
knot above her shoulder blade on her collar bone; swollen gland around her left collarbone; back spasms; nausea; sore arm in her left arm which was the injection arm; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in Arm Left on 17Apr2021 (Batch/Lot Number: ER8733; Expiration Date: Jul2021) as 1ST DOSE, SINGLE for covid-19 immunisation. The patient's medical history was not reported. Concomitant medications included nifedipine (NIFEDIPINE) taken for blood pressure increased from Feb2021 and ongoing; betacarotene, bioflavonoids nos, biotin, calcium ascorbate, calcium pantothenate, calcium phosphate, choline bitartrate, chromic chloride, colecalciferol, copper sulfate, cyanocobalamin, folic acid, hesperidin, inositol, iron amino acid chelate, lycopene, lysine hydrochloride, magnesium oxide, manganese sulfate, molybdenum trioxide, nicotinamide, phytomenadione, potassium iodide, potassium sulfate, pyridoxine hydrochloride, retinol acetate, riboflavin, selenomethionine, silicon dioxide, colloidal, sodium borate decahydrate, thiamine mononitrate, tocopheryl acid succinate, ubidecarenone, zinc oxide (MULTIVITAMIN & MINERAL) taken for immune system disorder from 2020 and ongoing; 1-alpha-hydroxyvitamin d3 (1-ALPHA-HYDROXYVITAMIN D3) taken for immune system disorder, bone disorder from 2020 and ongoing. The patient stated she received her first Pfizer Covid vaccine dose on 17Apr2021. That same day she started to experience nausea which resolved. She also experienced a sore arm (injection arm was left arm) for a few days, which has resolved. She reported back spasms on 26Apr2021 which have since resolved. She stated she began to have a swollen gland around her left collarbone on 27Apr2021 which continues to be swollen. Around 5-6 days after, she experienced a knot above her shoulder blade, on her collar bone. She went to get her 2nd shot today, and told them about the knot, it does not hurt, and they advised she go see a doctor. The outcome of the event knot above her shoulder blade on her collar bone was unknown, event swollen gland around her left collarbone was not recovered while other events were recovered on an unspecified date.
Injection site itchy; Swelling on the injection site; Asthma; Injection site hardness; Injection site red; Body ache; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ASTHMA (Asthma), VACCINATION SITE INDURATION (Injection site hardness), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE SWELLING (Swelling on the injection site) and VACCINATION SITE ERYTHEMA (Injection site red) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE INDURATION (Injection site hardness), VACCINATION SITE ERYTHEMA (Injection site red), MYALGIA (Body ache), HEADACHE (Headache) and NAUSEA (Nausea). On 15-Jan-2021, the patient experienced ASTHMA (Asthma), VACCINATION SITE PRURITUS (Injection site itchy) and VACCINATION SITE SWELLING (Swelling on the injection site). On 08-Jan-2021, MYALGIA (Body ache), HEADACHE (Headache) and NAUSEA (Nausea) had resolved. At the time of the report, ASTHMA (Asthma) was resolving and VACCINATION SITE INDURATION (Injection site hardness), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE SWELLING (Swelling on the injection site) and VACCINATION SITE ERYTHEMA (Injection site red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter. Treatment included Benadryl inhaler.
Death; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (batch/lot number was not reported) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got a steroid shot in between his 2 doses of the vaccine and he fell dead the next day. The reporter stated that the reporter didn't know what manufacturer he received, but that he took steroids all the time. The patient died on an unspecified date. The cause of death was unknown. It was not reported if an autopsy was performed.  Information on the lot/batch number has been requested.; Reported Cause(s) of Death: Unknown cause of death
< 24 hours onset fever up to 102.7 TYL or ADVIL. < 24 hours onset local skin redness, swelling warmth BENADRYL/ice compressed. > 48 hours developed cough w/mucus production.
A report has been received from a Health Professional concerning a 20 year old, Female subject, who had  been receiving nasal FLUMIST Quadrivalent.  FLUMIST Quadrivalent started on 06-JAN-2015. The Health Professional (RN) reported that expired FLUMIST Quadrivalent was administered to a patient on 06-JAN-2015. FLUMIST Quadrivalent was discontinued on 06-JAN-2015. The outcome of the event of expired FLUMIST Quadrivalent administered is unknown. The report was considered to be non-serious.
High resting heart rate all next day 100-140, and a bad headache all day and neck pain; High resting heart rate all next day 100-140, and a bad headache all day and neck pain; High resting heart rate all next day 100-140, and a bad headache all day and neck pain; This is a spontaneous report from a contactable other health professional (patient). A 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in the right arm on 05May2021 at 16:45 (at the age of 36-years-old) (Batch/Lot number was not reported) as dose 2, single and via an unspecified route of administration, administered in the left arm on 12Apr2021 at 10:00 (at the age of 36-years-old) (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. Medical history included allergies to sulfa drugs. There were no concomitant medications. The patient was not pregnant at the time of the events. The patient did not have COVID prior to vaccination. The patient did not receive other vaccines in four weeks. No medication was received in two weeks. On an unspecified date, the patient experienced high resting heart rate all next day 100-140, and a bad headache all day and neck pain. No treatment was received for the events. The patient was not tested for COVID post-vaccination. The patient underwent lab tests and procedures which included heart rate: high, 100-140. The outcome of the events was recovered/resolved on an unspecified date.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
client arrived at vaccination table to receive moderna covid19 vaccine. RN verified verbally with both client and mother who was present that client was 18 years old. Mother and client both confirmed. Upon review at the observation station, it was noticed that the client was indeed under 18 years old.
Got sick; All he wants to do is sleep; He has no appetite; He cannot get enough to drink; He cannot get warm; He does not feel like he can get up; Running a temperature of 101.8 F; He has chills real bad; He is just tired; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Got sick), SOMNOLENCE (All he wants to do is sleep), DECREASED APPETITE (He has no appetite), DEHYDRATION (He cannot get enough to drink) and FEELING COLD (He cannot get warm) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced ILLNESS (Got sick). 13-Feb-2021, the patient experienced SOMNOLENCE (All he wants to do is sleep), DECREASED APPETITE (He has no appetite), DEHYDRATION (He cannot get enough to drink), FEELING COLD (He cannot get warm), ASTHENIA (He does not feel like he can get up), PYREXIA (Running a temperature of 101.8 F), CHILLS (He has chills real bad) and FATIGUE (He is just tired). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of Unknown. On 15-Feb-2021, PYREXIA (Running a temperature of 101.8 F) had resolved. On 16-Feb-2021, ILLNESS (Got sick), SOMNOLENCE (All he wants to do is sleep), DEHYDRATION (He cannot get enough to drink), FEELING COLD (He cannot get warm), ASTHENIA (He does not feel like he can get up) and CHILLS (He has chills real bad) had resolved. At the time of the report, DECREASED APPETITE (He has no appetite) and FATIGUE (He is just tired) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Feb-2021, Body temperature: 101.8 (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: added second dose
2 hours after vaccination experience some fullness in my right eustachian tube but hearing was normal. Next day I had mild buzzing in right ear but hearing was normal. Next day I had a profound deafness in right ear, sudden.
This spontaneous report as received from a health care worker refers to a unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with COMVAX. Dose, route, lot number and expiration date were not reported. The health care worker reported that COMVAX was improperly stored and administered to unspecified number of patients on unspecified dates. No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
Pt was given an adult purple cap Pfizer COVID vaccine in error. No adverse reaction noted at time of injection. Mother was notified of error made and possible side effects to watch for. She will follow up with any sign or symptoms of reaction related to vaccine.
Injection site arm shows significant redness covering injection site area and bicep. Patient noticed AM on day after vaccination. Skin feels warm. A part from arm soreness, patient reports no other symptoms. As of 1:53 PM on 11/13/15 symptoms are not worsening.
Extreme tenderness of bilateral thighs, right worse than left.  Would still walk, but limping.
79 yr old caller had first vaccine yesterday at 1425 (pfizer) late in the afternoon she had chills and pain in arm, mouth was sour. she hasnt been taking her potassium on large amount of diuretics for kidney and heart. she is on 2.5 mg eloquis. today she stayed in bed this am her temp was 100. an hour ago it was 101.3 adv apap for fever if ok with your medical situation, sx are normal for vaccine. ok to go for dr next week if f/u is needed. these sx are not contagious.
Within minutes of receiving the vaccine, the individual began vomiting, stated her throat was sore and she complained of having a hard time catching her breath. There was no temperature. Patient reclined for several minutes. Blood pressure machine errored. Pulse was good. When EMT's arrived they verified patient's blood pressure, pulse, oxygen, and blood glucose were normal and did not recommend transport to emergency room.
Pt was given the FLUZONE vaccine on 10/20/11 at 1pm. 9pm that same day pt. experienced feeling very cold, felt weak, her husband stated she fainted, the ambulance was called, her blood pressure was low unable to stand. Went to ER, they ran test and found nothing wrong.
Hives on the upper part of my body, face, trunk, arms, buttocks, and neck. I still, till this day, break up in hives.
No treatment necessary  I called pt and advised that they got an extra dose of the flu vaccine and to call us if they have any concerns or side affects
I experienced  extreme heart palpitations that keep going and I went to the ER. While I was waiting in the ER to see the doctor, my heart slowed down. The ER doctor took some blood samples and I was placed on a treadmill to have a stress test down. and did an MRI to take pictures of my heart. It showed that I has a 2% blockage. I was released from the ER even though I was still not feeling good. The ER doctor misdiagnosed me as having a heart attack from my blood work. The event caused me to lose weight and I haven't felt the same since. I also have a random coughing spell that comes and goes which I never had until I took the vaccine.  I had to wear a heart monitor for two weeks and I had one episode of heart palpitations and stopped taking the medication prescribed because it made me feel worse. I haven't had any further symptoms and will not be taking the booster shot because I'm afraid the same thing will happen again.
foot weird looking; difficulty in walking; intense itching on the archway of her foot; tightening pain; swelling and bumps; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (intense itching on the archway of her foot), PAIN IN EXTREMITY (tightening pain), PERIPHERAL SWELLING (swelling and bumps), FOOT DEFORMITY (foot weird looking) and GAIT DISTURBANCE (difficulty in walking) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M201A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PRURITUS (intense itching on the archway of her foot), PAIN IN EXTREMITY (tightening pain) and PERIPHERAL SWELLING (swelling and bumps). On an unknown date, the patient experienced FOOT DEFORMITY (foot weird looking) and GAIT DISTURBANCE (difficulty in walking). At the time of the report, PRURITUS (intense itching on the archway of her foot), PAIN IN EXTREMITY (tightening pain), PERIPHERAL SWELLING (swelling and bumps), FOOT DEFORMITY (foot weird looking) and GAIT DISTURBANCE (difficulty in walking) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-338463 (Patient Link).
Vaccine given to pt. 20 minutes later pt passed out on floor, immediately responded to name. Blood pressure stable. Dr arrived. Pt ok at 15 minutes. Vital signs stable before pt left office.
Swelling, redness from shoulder to elbow. Patient received pneumococcal on 5/27/03 but vaccine was stored too cold.
Pt presented to the physician's office with varicella. It was described as small, scattered, crusted lesions that appeared somewhat vesicular. The pts fever lasted for about 2 days. Additional information has been requested.
Case number PHHY2012HR086860, is an initial spontaneous report received from agency press report on 03 Oct 2012. This report refers to an unspecified patient (age and gender). His medical history and concomitant medications were not reported. The patient was vaccinated with FLUIMUN (batch number: unknown) in Dec 2011. The patient experienced neurological symptoms (description of reported side effect, according to available data, does not fit the definition of GBS) from an unknown date. Connection between reported symptoms and applied vaccine was evaluated possible, but other possible causes, such as infections, and medications used in that time period, cannot be excluded. Official follow up information from agency should follow. Event outcome, seriousness and causality assessment were not reported.
No adverse effects; 12 month old patient was administered a dose of GARDASIL 9; This spontaneous report has been received from a nurse referring to a 12 month old patient of unknown gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not provided.  On 28-DEC-2012, the patient was vaccinated with a dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL) for prophylaxis (strength, dose, frequency, route, lot# and expiration date were not provided) (inappropriate age at vaccine administration). No adverse effects. The outcome of the events was unknown. No product quality complaint (PQC) involved.
High fever (reduced to 100.6 degrees F); Aches; Chills; Sweats; This is a spontaneous report received from a contactable consumer, the patient. A 50-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via an unspecified route of administration in right arm on 16Mar2021 at 15:00 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9269) via an unspecified route of administration in right arm on 23Feb2021 at 12:00(at the age of 50-years-old) as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. On 17Mar2021, patient experienced High fever (reduced to 100.6 degrees F), sweats, chills and aches at 02:15. Therapeutic measures were taken as a result of fever and included treatment with repeated Tylenol doses six hours apart. The clinical outcome of the high fever, sweats, chills and aches was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
patient became dizzy almost immediately upon standing  after imz .   asked wife for something to drink before she received her covid imz.  he started fanning himself.  i asked technician to come stand with him and observe while i attended to his wife's imz.  i checked his bp because i wasn't sure if he was just anxious (both he and his wife reported that he always got nervous with shots even though he had received numerous imz.  his blood pressure was 88/58mmhg with hr of 48.  i got a mat to have him lie on the floor to elevate his feet but he declined.  he sat another 10 minutes and said he felt better and said he was ok to leave with his wife without further assistance.
A female patient, of an unspecified age, received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# unknown), via unspecified route of administration, on May 1, 2021, single dose, for COVID-19 immunization. The patient's medical history and concomitant medication not reported. The patient previously received the 1st dose of  BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, batch/lot# unknown), via an unspecified route of administration, on an unspecified date, single dose, for COVID-19 immunization. On an unspecified date in May 2021, patient was sick. She did not feel well for 24 hours: GI issues, fever, chills, night sweats, headache and loss of appetite. The outcome of did not feel well for 24 hours' recovered on an unspecified date May 2021; while of remaining events: unknown. No follow-up attempts needed. Information about batch/lot number cannot be obtained.
Inflammation and lesions on right arm x2,  Pain across both upper extremities and febrile and lymph node involvement, ongoing.  No improvement.  Been seen per primary care, urgent care and ER.  16 months ongoing.  Now on  steroid ointment Triamcinolone.
Had 30 minutes of tongue and lip tingling which resolved.  Then had 2 weeks of headaches that were much worse with Valsalva or forward lean.  Headaches resolved but returned after second dose along with dramatic enlargement of right axillary lymph nodes.  Lymphadenopathy resolved in 2 months but positional headaches and Valsalva triggered headaches did not resolve until 6 months out.At this point the headaches are not entirely gone but are much much better and patient can function again instead of having to take long naps every day to control pain.  Accompanying pulsatile tinnitus has resolved although it briefly recurs sometimes.  Lurching gait remains a problem.
METALLIC TASTE IN MOUTH STARTING THE DAY AFTER VACCINATION, AND HAS CONTINUED SINCE THEN.
client fully vaccinated, patient died 09/05/2021-Cause: Complications of COVID-19
PT NOTICED AS SHE WAS LAYING DOWN TO GO TO BED THAT HER ARM HAD SWELLED (TRICEP), IT WAS HOT TO THE TOUCH FOR 24 HOURS AFTERWARD AND TODAY (48 HOURS AFTERWARD IS WARM TO THE TOUCH) PT COMPLAINS OF ARM STIFFNES UP TO 48 HOURS AFTER PNUEMOVAX SHOT AND REPORTS THAT SHE ALSO HAD NAUSEA AND FEVER FOR 24 HOURS POST VACCINATION. ARM IS STILL RED UP TO 48 HOURS POST VACCINATION.